{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Hepatic+Complications&page=2", "query": { "condition": "Hepatic Complications", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Hepatic+Complications&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-06-27T01:13:30.533Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04613921", "title": "Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Liver Diseases", "Liver Cirrhosis", "Acute-On-Chronic Liver Failure", "Liver Transplant; Complications" ], "interventions": [ { "name": "Observational Protocol", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "European Foundation for Study of Chronic Liver Failure", "sponsor_class": "OTHER", "healthy_volunteers": null, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 3000, "start_date": "2021-07-08", "completion_date": "2026-12-31", "has_results": false, "last_update_posted_date": "2025-10-20", "last_synced_at": "2026-06-27T01:13:30.533Z", "location_count": 18, "location_summary": "Los Angeles, California • Aurora, Colorado • Tampa, Florida + 11 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Tampa", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT04613921" }, { "nct_id": "NCT05593211", "title": "Assess Safety and Performance of the Kronos Electrocautery Device for Electrocautery Procedures Following Coaxial Biopsy Procedures", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hepatic Disease", "Renal Disease" ], "interventions": [ { "name": "Kronos Electrocautery Device", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Single Pass Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 31, "start_date": "2022-10-17", "completion_date": "2023-02-09", "has_results": true, "last_update_posted_date": "2023-06-27", "last_synced_at": "2026-06-27T01:13:30.533Z", "location_count": 1, "location_summary": "Long Beach, California", "locations": [ { "city": "Long Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05593211" }, { "nct_id": "NCT01401998", "title": "ARPKD Database Study", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Hepato/Renal Fibrocystic Disease", "Autosomal Recessive Polycystic Kidney Disease", "Joubert Syndrome", "Bardet Biedl Syndrome", "Meckel-Gruber Syndrome", "Congenital Hepatic Fibrosis", "Caroli Syndrome", "Oro-Facial-Digital Syndrome Type I", "Nephronophthisis", "Glomerulocystic Kidney Disease" ], "interventions": [], "intervention_types": [], "sponsor": "Children's Hospital of Philadelphia", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "18 Years", "sex": "ALL", "summary": "Up to 18 Years" }, "enrollment_count": 200, "start_date": "2011-06", "completion_date": "2030-12", "has_results": false, "last_update_posted_date": "2026-06-15", "last_synced_at": "2026-06-27T01:13:30.533Z", "location_count": 6, "location_summary": "Washington D.C., District of Columbia • Atlanta, Georgia • Boston, Massachusetts + 3 more", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Cincinnati", "state": "Ohio" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01401998" }, { "nct_id": "NCT00457938", "title": "Novel Therapies for Metabolic Complications of Lipodystrophies", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Insulin Resistance", "Hypertriglyceridemia", "Diabetes", "Hepatic Steatosis" ], "interventions": [ { "name": "low-fat diet ( Still recruiting )", "type": "OTHER" }, { "name": "Diet", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Texas Southwestern Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "14 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "14 Years to 70 Years" }, "enrollment_count": 4, "start_date": "2006-04", "completion_date": "2014-11", "has_results": false, "last_update_posted_date": "2018-10-16", "last_synced_at": "2026-06-27T01:13:30.533Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00457938" }, { "nct_id": "NCT03359850", "title": "Pharmacokinetic and Safety Study of Niraparib With Normal or Moderate Hepatic Impairment Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Ovarian Neoplasms", "Neoplasms", "Solid Tumor", "Hepatic Impairment" ], "interventions": [ { "name": "Niraparib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Tesaro, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 17, "start_date": "2018-02-20", "completion_date": "2020-06-24", "has_results": true, "last_update_posted_date": "2021-05-28", "last_synced_at": "2026-06-27T01:13:30.533Z", "location_count": 5, "location_summary": "Los Angeles, California • Newport Beach, California • Aurora, Colorado + 2 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03359850" }, { "nct_id": "NCT03329950", "title": "A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Melanoma", "Non-small Cell Lung Cancer", "Breast Cancer", "Gastric Cancer", "Renal Cell Carcinoma", "Ovarian Cancer", "Cholangiocarcinoma", "Bladder Urothelial Carcinoma", "Pancreatic Adenocarcinoma", "Colorectal Cancer", "Esophageal Cancer", "Hepatic Cancer", "Head and Neck Cancer", "Primary Peritoneal Cancer", "Fallopian Tube Cancer", "Other Solid Tumors", "Diffuse Large B-cell Lymphoma (DLBCL)", "Mantle Cell Lymphoma", "Indolent B-cell Lymphomas", "Non-Hodgkin Lymphoma", "Follicular Lymphoma", "Lymphoplasmacytic Lymphoma", "Waldenstrom's Disease", "Marginal Zone Lymphoma", "Mucosa Associated Lymphoid Tissue", "Small Lymphocytic Leukemia" ], "interventions": [ { "name": "CDX-1140", "type": "DRUG" }, { "name": "CDX-301", "type": "DRUG" }, { "name": "pembrolizumab", "type": "DRUG" }, { "name": "Chemotherapy", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Celldex Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 132, "start_date": "2017-12-01", "completion_date": "2022-09-13", "has_results": false, "last_update_posted_date": "2024-03-28", "last_synced_at": "2026-06-27T01:13:30.533Z", "location_count": 11, "location_summary": "Scottsdale, Arizona • Atlanta, Georgia • Augusta, Georgia + 7 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Augusta", "state": "Georgia" }, { "city": "Omaha", "state": "Nebraska" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03329950" }, { "nct_id": "NCT00884520", "title": "An Exploratory, Open Label, Multi-Center, Non-Randomized Study of [F-18]VM4-037", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Lung Cancer", "Squamous Cell Carcinoma", "Head and Neck Cancer", "Hepatic Carcinoma", "Renal Cell Carcinoma" ], "interventions": [ { "name": "[F-18] VM4-037", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Siemens Molecular Imaging", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 16, "start_date": "2009-04", "completion_date": "2010-03", "has_results": false, "last_update_posted_date": "2010-03-16", "last_synced_at": "2026-06-27T01:13:30.533Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00884520" }, { "nct_id": "NCT07517198", "title": "Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Solid Tumor", "Small Cell Lung Cancer (SCLC)", "High Grade Neuroendocrine Cancer", "Small Cell Carcinomas of Non-lung Origin", "Non-small Cell Lung Cancer (NSCLC)", "Prostate Cancer", "Ovarian Cancer", "Renal Carcinoma (Clear and Non-clear Cell)", "Head and Neck Squamous Cell Carcinoma (HNSCC)", "Hepatic Cancer", "Gastric Cancer", "Triple-negative Breast Cancer (TNBC)" ], "interventions": [ { "name": "EXS74539", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 40, "start_date": "2026-04-13", "completion_date": "2029-03", "has_results": false, "last_update_posted_date": "2026-06-10", "last_synced_at": "2026-06-27T01:13:30.533Z", "location_count": 3, "location_summary": "Los Angeles, California • Fort Worth, Texas • West Valley City, Utah", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Fort Worth", "state": "Texas" }, { "city": "West Valley City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT07517198" }, { "nct_id": "NCT03534141", "title": "Mild Hypothermia and Acute Kidney Injury in Liver Transplantation", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cirrhosis", "End Stage Liver Disease", "Acute Kidney Injury", "Liver Transplant; Complications", "Chronic Kidney Diseases", "Hepatitis c", "Hepatitis B", "NASH - Nonalcoholic Steatohepatitis", "Alcoholic Cirrhosis", "Hepatocellular Carcinoma" ], "interventions": [ { "name": "Esophageal cooling/warming device", "type": "DEVICE" }, { "name": "Mild hypothermia", "type": "OTHER" }, { "name": "Normothermia", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "OTHER" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 175, "start_date": "2018-07-07", "completion_date": "2023-09-14", "has_results": true, "last_update_posted_date": "2025-05-16", "last_synced_at": "2026-06-27T01:13:30.533Z", "location_count": 3, "location_summary": "San Francisco, California • Aurora, Colorado • Houston, Texas", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03534141" }, { "nct_id": "NCT00238693", "title": "Transplant Patient Registry of Liver, Kidney and/or Pancreas", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "End Stage Renal Disease", "End Stage Liver Disease" ], "interventions": [], "intervention_types": [], "sponsor": "Virginia Commonwealth University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 13767, "start_date": "2003-04", "completion_date": "2018-08-27", "has_results": false, "last_update_posted_date": "2018-09-25", "last_synced_at": "2026-06-27T01:13:30.533Z", "location_count": 1, "location_summary": "Richmond, Virginia", "locations": [ { "city": "Richmond", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00238693" } ] }